 - Measurable, direct manifestations of myeloma must be present, such as monoclonal serum or urine globulins. Plasma cell tumors must also be documented. Patients without protein criteria are eligible if bone marrow has 30 plasmacytosis documented by bilateral bone marrow aspirations and biopsies. 